These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19124394)
61. The Promising Frontier of Cardiometabolic Syndrome: A New Paradigm in Cardiology. Khan AR; Salama AH; Aleem Z; Alfakeer H; Alnemr L; Shareef AMM Cureus; 2023 Sep; 15(9):e45542. PubMed ID: 37868505 [TBL] [Abstract][Full Text] [Related]
62. Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors. Wilson PW; Black HR; Fabricatore AN; Goldberg IJ J Cardiometab Syndr; 2008; 3(3):177-82. PubMed ID: 18983336 [TBL] [Abstract][Full Text] [Related]
63. Bibliography. Current world literature. Genetics and molecular biology. Curr Opin Lipidol; 2008 Apr; 19(2):168-200. PubMed ID: 18388697 [No Abstract] [Full Text] [Related]
64. Building genetic scores to predict risk of complex diseases in humans: is it possible? Liu S; Song Y Diabetes; 2010 Nov; 59(11):2729-31. PubMed ID: 20980472 [No Abstract] [Full Text] [Related]
65. Gaining insights in coronary disease genomics. Murray SS; Topol EJ J Am Coll Cardiol; 2008 Jul; 52(5):385-6. PubMed ID: 18652947 [No Abstract] [Full Text] [Related]
66. [Genomics in cardiological clinical practice: from the individual response to drug therapy and monogenic cardiovascular disorders]. Marziliano N; Orsini F; Veronese S; Colosimo A; Lauricella C; Motta V; Gambacorta M; Mauri F; Ardissino D; Merlini PA G Ital Cardiol (Rome); 2010 Oct; 11(10):767-8. PubMed ID: 21246778 [No Abstract] [Full Text] [Related]
68. Genomics and the cardiac surgeon. Bullard MK; Swift M; Harken A J Card Surg; 2007; 22(1):83-6. PubMed ID: 17239225 [TBL] [Abstract][Full Text] [Related]
69. A polygenic model for integration of linkage and pathway information. Lebrec JJ; Nishchenko I; van der Wijk HJ; Huizinga TW; van Houwelingen HC Genet Epidemiol; 2009 Apr; 33(3):198-206. PubMed ID: 18979499 [TBL] [Abstract][Full Text] [Related]
70. New approaches to establish genetic causality. McNally EM; George AL Trends Cardiovasc Med; 2015 Oct; 25(7):646-52. PubMed ID: 25864169 [TBL] [Abstract][Full Text] [Related]
71. Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk? Aronis KN; Kim YB; Mantzoros CS Metabolism; 2011 Jun; 60(6):747-8. PubMed ID: 21333309 [No Abstract] [Full Text] [Related]
72. The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases. Zeljkovic A; Mihajlovic M; Vujcic S; Guzonjic A; Munjas J; Stefanovic A; Kotur-Stevuljevic J; Rizzo M; Bogavac-Stanojevic N; Gagic J; Kostadinovic J; Vekic J Curr Vasc Pharmacol; 2023; 21(3):185-196. PubMed ID: 37165508 [TBL] [Abstract][Full Text] [Related]
73. Genetics of cardiovascular disease: interplay between common and rare alleles. Melander O J Hypertens; 2008 Mar; 26(3):394-5. PubMed ID: 18300845 [No Abstract] [Full Text] [Related]